Van ECK Associates Corp boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 11.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 69,623 shares of the medical equipment provider’s stock after buying an additional 7,430 shares during the quarter. Van ECK Associates Corp’s holdings in Intuitive Surgical were worth $35,687,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of ISRG. Ullmann Wealth Partners Group LLC grew its stake in Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares in the last quarter. One Wealth Management Investment & Advisory Services LLC grew its stake in shares of Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares in the last quarter. Daymark Wealth Partners LLC increased its holdings in Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after buying an additional 24 shares during the last quarter. Indiana Trust & Investment Management CO raised its position in Intuitive Surgical by 5.3% during the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after acquiring an additional 25 shares in the last quarter. Finally, Hoxton Planning & Management LLC lifted its stake in Intuitive Surgical by 4.9% in the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after acquiring an additional 25 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Trading Up 0.2 %
Shares of NASDAQ ISRG opened at $507.42 on Tuesday. The firm has a market capitalization of $180.73 billion, a price-to-earnings ratio of 81.58, a PEG ratio of 4.95 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $269.49 and a one year high of $523.34. The business has a fifty day simple moving average of $490.97 and a 200 day simple moving average of $448.54.
Insider Activity
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on ISRG shares. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. BTIG Research set a $535.00 target price on Intuitive Surgical in a report on Friday, October 18th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price target for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Mizuho upped their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.
Get Our Latest Analysis on ISRG
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- How to Calculate Return on Investment (ROI)
- Intel: Is Now the Time to Be Brave?Â
- How to Use Stock Screeners to Find Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is the Shanghai Stock Exchange Composite Index?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.